Amlodipine/atorvastatin

Amlodipine/atorvastatin
Combination of
AmlodipineCalcium channel blocker
AtorvastatinStatin
Clinical data
Trade namesCaduet, Envacar, others
AHFS/Drugs.comProfessional Drug Facts
License data
Pregnancy
category
  • AU: D
  • Contraindicated
Routes of
administration		By mouth
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • US: ℞-only
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
KEGG
CompTox Dashboard (EPA)
  (verify)

Amlodipine/atorvastatin, sold under the brand name Caduet among others, is a fixed-dose combination medication for the treatment of high cholesterol and high blood pressure. It contains a statin and a calcium channel blocker.

Society and culture

Brand names

Amlodipine/atorvastatin is marketed under the brand name Caduet in the United States, Australia, and Russia, and Envacar in the Philippines.

In some countries Caduet is marketed by Viatris after Upjohn was spun off from Pfizer.

References

  1. ↑ Curran MP (2010). "Amlodipine/Atorvastatin". Drugs. 70 (2). Springer Science+Business Media: 191–213. doi:10.2165/11204420-000000000-00000. ISSN 0012-6667. PMID 20108992. S2CID 209144335.
  2. ↑ Devabhaktuni M, Bangalore S (2009). "Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives". Vascular Health and Risk Management. 5 (1): 377–87. doi:10.2147/vhrm.s3339. PMC 2686256. PMID 19475775.
  3. ↑ "Caduet - Drugs.com". Archived from the original on 19 June 2014.
  4. ↑ "Envacar - Drugs.com". Archived from the original on 20 June 2014.
  5. ↑ "Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan". Pfizer. 16 November 2020. Retrieved 17 June 2024 – via Business Wire.
  6. ↑ "Caduet". Pfizer. Retrieved 17 June 2024.
  7. ↑ "Brands". Viatris. 16 November 2020. Retrieved 17 June 2024.